3PEQ

PPARd complexed with a phenoxyacetic acid partial agonist


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.237 
  • R-Value Work: 0.199 
  • R-Value Observed: 0.201 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Phenoxyacetic acid PPARd partial agonists for the treatment of type 2 diabetes: synthesis, optimization, and in vivo efficacy

Evans, K.A.Shearer, B.G.Wisnoski, D.D.Shi, D.Sparks, S.M.Sternbach, D.D.Winegar, D.A.Billin, A.N.Britt, C.Way, J.M.Epperly, A.H.Leesnitzer, L.M.Merrihew, R.V.Xu, R.X.Lambert, M.H.Jin, J.

(2011) Bioorg Med Chem Lett 21: 2345-2350

  • DOI: 10.1016/j.bmcl.2011.02.077
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • A series of phenoxyacetic acids as subtype selective and potent hPPARδ partial agonists is described. Many analogues were readily accessible via a single solution-phase synthetic route which resulted in the rapid identification of key structure-activ ...

    A series of phenoxyacetic acids as subtype selective and potent hPPARδ partial agonists is described. Many analogues were readily accessible via a single solution-phase synthetic route which resulted in the rapid identification of key structure-activity relationships (SAR), and the discovery of two potent exemplars which were further evaluated in vivo. Details of the SAR, optimization, and in vivo efficacy of this series are presented herein.


    Organizational Affiliation

    Discovery Medicinal Chemistry, Discovery Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Road, PO Box 5089, Collegeville, PA 19426-0989, United States. karen.a.evans@gsk.com



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Peroxisome proliferator-activated receptor delta
A, B
271Homo sapiensMutation(s): 0 
Gene Names: NR1C2PPARBPPARD
Find proteins for Q03181 (Homo sapiens)
Go to UniProtKB:  Q03181
NIH Common Fund Data Resources
PHAROS  Q03181
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
3EQ
Query on 3EQ

Download CCD File 
A, B
[(4-{butyl[2-methyl-4'-(methylsulfanyl)biphenyl-3-yl]sulfamoyl}naphthalen-1-yl)oxy]acetic acid
C30 H31 N O5 S2
XUMLNRUSPQDSIN-UHFFFAOYSA-N
 Ligand Interaction
JZR
Query on JZR

Download CCD File 
A, B
hexyl beta-D-glucopyranoside
C12 H24 O6
JVAZJLFFSJARQM-RMPHRYRLSA-N
 Ligand Interaction
IOD
Query on IOD

Download CCD File 
A, B
IODIDE ION
I
XMBWDFGMSWQBCA-UHFFFAOYSA-M
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
3EQIC50:  32   nM  Binding MOAD
3EQIC50 :  31.600000381469727   nM  PDBBind
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.237 
  • R-Value Work: 0.199 
  • R-Value Observed: 0.201 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 39.472α = 90
b = 95.535β = 97.76
c = 96.537γ = 90
Software Package:
Software NamePurpose
ADSCdata collection
AMoREphasing
REFMACrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2011-10-12
    Type: Initial release
  • Version 1.1: 2014-10-08
    Changes: Database references